R.PR
REGISTERED-PRINCIPAL REGISTER
03/22/2022
Back to search
Official data from USPTO
PHARMACEUTICAL SECURITY INSTITUTE ESTABLISHED 2002
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
03/22/2022
Trademark type
Combined
Nice classes
45
Filing date
04/01/2021
Registration date
03/22/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/22/2022
Last transaction
03/22/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
09/01/2016
First use in commerce
09/01/2016
Drawing code
3
Owner type
99
Owner location
Vienna, VA, US
Examiner
HWANG, JOHN
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "PHARMACEUTICAL SECURITY INSTITUTE" forming a circle around a stylized Greek letter psi and with the word and numbers "ESTABLISHED 2002" below the letter psi.
Holders and representatives
Holders
Pharmaceutical Security Institute, Inc.
Representatives
Beth M. Goldman ORRICK, HERRINGTON & SUTCLIFFE LLP
Technical classification
Nice Classes
Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 45
Consulting servicesconsultation in the fields of product and document authentication and trackingbrand monitoring and protectionto protect against counterfeitingtamperingdiversionto ensure the integrity of genuine products and documents
Publications
History of USPTO decisions and trademark events.
19 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/04/2022
PUBO
PUBLISHED FOR OPPOSITION
01/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/15/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/29/2021
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
11/29/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/29/2021
ALIE
ASSIGNED TO LIE
11/29/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
11/23/2021
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
11/18/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
11/18/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/18/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
11/18/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/18/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/18/2021
DOCK
ASSIGNED TO EXAMINER
11/15/2021
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/09/2021
NWAP
NEW APPLICATION ENTERED
04/05/2021
Continuous trademark protection
Get notified about every new filing that threatens PHARMACEUTICAL SECURITY INSTITUTE ESTABLISHED 2002 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.